Xtx Topco LTD Volitionrx LTD Transaction History
Xtx Topco LTD
- $1.13 Billion
- Q4 2024
A detailed history of Xtx Topco LTD transactions in Volitionrx LTD stock. As of the latest transaction made, Xtx Topco LTD holds 21,359 shares of VNRX stock, worth $11,961. This represents 0.0% of its overall portfolio holdings.
Number of Shares
21,359Holding current value
$11,961% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding VNRX
# of Institutions
28Shares Held
17.8MCall Options Held
41KPut Options Held
100-
Armistice Capital, LLC New York, NY9MShares$5.04 Million0.09% of portfolio
-
Lagoda Investment Management, L.P. New York, NY6.1MShares$3.41 Million2.11% of portfolio
-
Geode Capital Management, LLC Boston, MA744KShares$416,5520.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA637KShares$356,5330.0% of portfolio
-
Black Rock Inc. New York, NY516KShares$289,0000.0% of portfolio
About VOLITIONRX LTD
- Ticker VNRX
- Exchange NYSE
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 57,297,000
- Market Cap $32.1M
- Description
- VolitionRx Limited, a multi-national epigenetics company, engages in the development of blood tests to help diagnose a range of cancers and other diseases worldwide. It sells Nu.Q that detect cancer; Nu.Q Nets, monitoring the immune system; Nu.Q Vet cancer screening test for veterinary applications; Nu.Q Capture capturing and concentrating sampl...